Spatial and temporal genetic heterogeneity of epidermal growth factor receptor gene status in a patient with non-small cell lung cancer: a case report
<p>Abstract</p> <p>Introduction</p> <p>To date, an epidermal growth factor receptor-activating mutation is recognized as a genetic hallmark that predicts a good response to treatment with epidermal growth factor receptor tyrosine kinase inhibitor. However, there has bee...
Main Authors: | Ogata Makoto, Shimizu Toshiki, Yokoi Takashi, Nomura Shosaku |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | Journal of Medical Case Reports |
Online Access: | http://www.jmedicalcasereports.com/content/5/1/553 |
Similar Items
-
Platelet-related indices in patients with lung cancer with nivolumab
by: Shosaku Nomura, et al.
Published: (2018-02-01) -
Epidermal Growth Factor Receptor Mutation Status and the Impact on Clinical Outcomes in Patients with Non-Small Cell Lung Cancer
by: Huang HM, et al.
Published: (2022-12-01) -
FDG PET texture indices as imaging biomarkers for epidermal growth factor receptor mutation status in lung adenocarcinoma
by: Mariko Ishimura, et al.
Published: (2023-04-01) -
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
by: Connor O’Leary, et al.
Published: (2020-09-01) -
Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer
by: Wei Zhao, et al.
Published: (2022-11-01)